Cellular biomarker
Showing 1 - 25 of 6,369
Novel Biomarker Assay for Biomarker Assay for HCC Detection
Not yet recruiting
- Hepato-cellular Carcinoma
- (no location specified)
Aug 8, 2022
Heart Failure, Inflammation, Colchicine Trial in Montréal (Colchicine, Placebo)
Recruiting
- Heart Failure
- +2 more
- Colchicine
- Placebo
-
Montréal, Quebec, CanadaMontreal Heart Institute
Dec 27, 2022
Urine-DNA Biomarkers in Detecting Bladder Cancer
Completed
- Bladder Cancer
- +3 more
- Next generation sequencing
-
Changsha, Hunan, ChinaXiangya Hospital of Central South Univeristy
Nov 7, 2022
Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)
Terminated
- Merkel Cell Polyomavirus Infection
- Stage IV Merkel Cell Carcinoma AJCC v7
- Avelumab
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 25, 2022
Insulin Resistance Syndrome Trial in France (Dosage of IRAP during OGTT)
Terminated
- Insulin Resistance Syndrome
- Dosage of IRAP during OGTT
-
Clermont-Ferrand, France
- +3 more
Aug 8, 2022
Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH
Recruiting
- Chronic Graft-versus-Host-Disease
- +4 more
-
San Francisco, California
- +15 more
Jun 17, 2022
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,
Recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +20 more
- Chimeric Antigen Receptor T-Cell Therapy
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 11, 2022
Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in
Completed
- Stage III Cutaneous Melanoma AJCC v7
- +5 more
- Aldesleukin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2022
COVID-19 Infection, Hematopoietic and Lymphoid System Tumor, Leukemia Trial in Duarte (COVID-19 Vaccine, Diagnostic Laboratory
Recruiting
- COVID-19 Infection
- +4 more
- COVID-19 Vaccine
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 2, 2021
Panic Disorder Trial in Jerusalem (CBT- both internet and face to face, No intervention)
Unknown status
- Panic Disorder
- CBT- both internet and face to face
- No intervention
-
Jerusalem, IsraelHebrew University of Jerusalem
Feb 8, 2021
Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)
Active, not recruiting
- Metastatic Melanoma
- Stage IV Cutaneous Melanoma AJCC v6 and v7
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Recurrent DLBCL, Recurrent Mantle Cell Lymphoma, Refractory DLBCL Trial in Duarte (Autologous
Active, not recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +4 more
- Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 28, 2022
Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +23 more
- autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte
Active, not recruiting
- Adult Acute Myeloid Leukemia in Remission
- +12 more
- cyclophosphamide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Colorectal Adenocarcinoma, Metastatic Cholangiocarcinoma, Metastatic Colorectal Carcinoma Trial in Houston (biological, drug,
Terminated
- Colorectal Adenocarcinoma
- +12 more
- Adoptive Immunotherapy
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Oct 28, 2020
Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma Trial in
Terminated
- Advanced Pleural Malignant Mesothelioma
- +10 more
- Aldesleukin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 16, 2021
Neutrophil-derived ROS Production beNovel Biomarker of Sepsis?
Completed
- Infections
- +2 more
- The Leukocyte ImmunoTest™ (LIT™)
-
Ankara, Yenimahalle, TurkeyGazi University
Jul 20, 2023
Therapeutic Plasma Exchange on RNA Biomarker Expression Levels
Recruiting
- Alzheimer Disease
-
Brentwood, TennesseeThe MaxWell Clinic
Oct 11, 2023
Rejection in Liver Transplant Patients
Active, not recruiting
- Liver Transplant Rejection
- Liver Transplant Failure and Rejection
- N/A-Observational Study
-
Saint Louis, MissouriSSM Health Cardinal Glennon Children's Hospital & Saint Louis Un
Nov 29, 2023
Type 2 Diabetes Trial in Washington (Saxagliptin, Placebo)
Completed
- Type 2 Diabetes
- Saxagliptin
- Placebo
-
Washington, District of ColumbiaMedical Faculty Associates Inc
Jan 30, 2019
Sickle Cell Disease Trial in Pittsburgh (Skin Hydration Sensor)
Recruiting
- Sickle Cell Disease
- Skin Hydration Sensor
-
Pittsburgh, PennsylvaniaUPMC Sickle Cell Clinic
Apr 6, 2022
Colorectal Cancer Trial in France (ccfDNA analysis)
Completed
- Colorectal Cancer
- ccfDNA analysis
-
Aurillac, France
- +18 more
Aug 1, 2022
Validate the Imaging Biomarker for NCP (R33)
Recruiting
- Dry Eye Syndromes
- Corneal Disease
- In vivo confocal microscopy (IVCM)
-
Boston, Massachusetts
- +1 more
Jan 18, 2023
Serum, Cellular and Imaging Markers of Arthritis in Psoriasis
Active, not recruiting
- Psoriasis
-
Rochester, New YorkUniversity of Rochester
Jan 20, 2022
Mitochondrial DNA Copy Number and Leukocyte Telomere Length as
Recruiting
- Type 2 Diabetes Mellitus
- Genotyping
-
Sohag, EgyptSohag Univversity
Jan 12, 2023